Sponsors (9)
The bill increases accountability, transparency, and ethical safeguards to combat forced organ harvesting and limits U.S. complicity, but does so at the cost of potential harms to medical/scientific collaboration, economic and diplomatic flexibility, and some civil‑liberties and intelligence risks.
Victims of forced organ harvesting and advocates will get greater accountability because the bill enables targeted sanctions, visa bans, and asset-blocking against foreign individuals and entities involved in involuntary organ harvesting.
U.S. policymakers, oversight bodies, and the public will gain more transparency about PRC transplant practices and past U.S.-linked research collaborations because the bill requires evidence-based reporting and lists of grants, improving the information base for sanctions, diplomacy, and prevention efforts.
Patients, clinicians, and U.S. institutions are less likely to be complicit in unethical transplant practices because the bill limits certain U.S. participation and reinforces public-health and ethical standards around organ transplantation.
Patients, clinicians, and researchers could face slower medical/scientific progress and reduced training or treatment options because the bill may restrict legitimate collaboration with PRC institutions and lead institutions to avoid partnerships over compliance risk.
U.S. businesses, financial institutions, and consumers could incur higher costs or disrupted commerce because targeted sanctions, broad IEEPA authority, criminal penalties, and possible retaliatory measures may chill lawful transactions and raise compliance burdens.
Immigrants and foreign persons could suffer severe travel and financial disruption if wrongly listed, because visa revocations and asset freezes can be imposed quickly and carry heavy practical consequences.
Based on analysis of 6 sections of legislative text.
Directs the President to sanction foreign persons involved in involuntary organ harvesting in China, requires a U.S. report on Chinese transplant practices, and imposes visa and asset restrictions with defined exceptions.
Creates a U.S. policy and enforcement framework to respond to allegations of state-sponsored involuntary organ harvesting in the People’s Republic of China. It requires the President to identify and impose targeted sanctions and visa restrictions on foreign persons who knowingly participated in or facilitated such practices, directs a detailed U.S. government report on China’s transplant policies and practices, and sets rules for timing, exceptions, and a five-year sunset on the sanctions authority. The law also limits the measure’s reach by excluding import bans, protecting humanitarian and authorized intelligence or law-enforcement activities, allowing case-by-case national security waivers, and requiring public reporting and congressional notifications of lists, sanctions, and waiver use.
Introduced March 3, 2025 by Rafael Edward Cruz · Last progress March 3, 2025